The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 2 of the 39 sources its claims cite were checked for support.
Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples
Open accessAbstract
To improve the prognosis of advanced esophageal cancer, neoadjuvant chemotherapy (NACT) followed by surgery is a promising treatment strategy. NACT has been shown to improve the prognosis of responders. However, non-responders not only suffer from side-effects, but they also lose precious time to take advantage of other possible treatments. Therefore, it is crucial to establish a reliable method that allows prediction of response before chemotherapy. A biopsy sample can provide valuable information on the biological characteristics of an individual esophageal cancer, which can affect chemosensitivity. Comprehensive gene expression profiling (GEP) using oligonucleotide microarray covering 30,000 human probes was performed in 50 pretreatment endoscopic biopsy samples from 25 patients with esophageal squamous cell cancer (ESCC) who underwent cisplatin-based chemotherapy (two samples per patient). Chemotherapeutic responses were evaluated by the reduction rate of the tumor area on CT scans. Responders were defined as patients with reduction rates of ≥50% and non-responders were defined as patients with <50% decrease. The diagnostic system, that predicts responses to chemotherapy, was constructed with the 199 most informative genes, and showed 82% of accuracy. Furthermore, the predictive performance of this system was confirmed using an additional ten samples with an accuracy of 80%. This study shows that GEP of pretreatment ESCC biopsy samples has the potential to predict responses to chemotherapy.
Overview
CoChat Summary
## TL;DR
This study used pretreatment endoscopic biopsy gene-expression profiling to predict response to cisplatin-based chemotherapy in advanced esophageal squamous cell carcinoma (ESCC). A 199-gene diagnostic system achieved 82% accuracy in leave-one-out cross-validation and 80% accuracy in an independent 10-sample validation set.
## Key findings
- In the estimation set, 50 biopsy samples from 25 patients were profiled; when all 19,166 genes were used, complete leave-one-out cross-validation gave 72% accuracy.
- After filtering, the authors defined 199 predictive genes (P<0.001 by permutation test); leave-one-out cross-validation with these genes improved accuracy to 82%, with positive predictive value 88.2% (15/17) and negative predictive value 78.8% (26/33).
- In the independent validation set of 10 patients, the diagnostic system correctly predicted response in 8 of 10 cases (80.0% accuracy), with PPV 75.0% (3/4) and NPV 83.3% (5/6).
- qRT-PCR on 20 biopsy specimens for five selected genes (PERP, PRDX6, DAD1, SELPINB6, SRF) agreed with the microarray expression patterns.
## Methods
- Design: observational biomarker study building a gene-expression-based classifier from pretreatment biopsy samples, then testing it in an independent validation set.
- Data/sample: 50 pretreatment endoscopic biopsy samples from 25 ESCC patients in the estimation set (two samples per patient) and 10 additional pretreatment biopsy samples in the validation set; all patients received cisplatin-based FAP chemotherapy.
- Analysis: oligonucleotide microarray (30,000 human probes), background correction and filtering, hierarchical cluster analysis, permutation testing to select genes, weighted voting classifier, and leave-one-out cross-validation; qRT-PCR was used to verify five genes.
## Limitations
- The paper explicitly says the results “warrant validation of the predictive genes with a larger number of patients and eventually in a prospective trial to evaluate its utility.”
- Evident from the text: the validation set was small (10 patients), so the reported 80% accuracy is based on limited sample size.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
2 Valid · 0 Not valid · 21 Not checked · 39 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The diagnostic system, that predicts responses to chemotherapy, was constructed with the 199 most informative genes, and showed 82% of accuracy.”
plainstates an associationn = 50- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, the predictive performance of this system was confirmed using an additional ten samples with an accuracy of 80%.”
plainn = 10- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The expression patterns of 199 predictive genes showed distinct profiles between the two groups (Fig. 2).”
plainstates an associationn = 50- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When all 19,166 genes were used for prediction of response, the accuracy was 72% by the complete leaveone-out cross-validation.”
plainstates an associationn = 25- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this study, we performed GEP of 60 ESCC biopsies, and successfully predicted the responses to chemotherapy.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
24 more claims
Create a free account to see all 62 claims and to verify the 6 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 13
- The quote only partly states this claim. 3
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus
Akiyama, H., Tsurumaru, M., Udagawa, H., & Kajiyama, Y. (1994) · Annals of Surgery · doi:10.1097/00000658-199409000-00012 · Cited by 901
Weber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Ayers, M., Symmans, W. F., Stec, J., Damokosh, A. I., Clark, E., Hess, K., Lecocke, M., Metivier, J., Booser, D., Ibrahim, N., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.166 · Cited by 566
Gene expression profiling predicts clinical outcome of breast cancer
(2002) · Nature · doi:10.1038/news020128-6 · Cited by 533
Iizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
Wieder, H. A., Brücher, B. L. D. M., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Schwaiger, M., Fink, U., Siewert, J. R., Stein, H. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.122 · Cited by 454
Cited by
Chang, C., Ho, T., Lin, H., Liang, J., Huang, H.-C., Li, C., Lo, H., Wu, S., Huang, Y., & Hsiang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031808 · Cited by 158
“Microarray-based gene expression patterns have been used to predict the clinical outcome and prognosis of patients undergoing 5-FU therapy [28-30].”
Wen, J., Yang, H., Liu, M.-L., Luo, K. J., Liu, H., Hu, Y., Zhang, X., Lai, R., Lin, T., Wang, H., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu201 · Cited by 91
“The number of differential expressed genes is smaller than that of some other reports [7–11].”
BackgroundMethodResultMotoori, M., Yano, M., Ishihara, R., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2231-8 · Cited by 87
“In addition, molecular analyses, such as RT-PCR, immunohistochemistry, and gene expression profiling, have been performed to understand biological characteristics of esophageal cancer.(17,18) In the future, molecular analysis of pretreatment biopsy samples may predict pathologic lymph node metastasis in superficial es…”
Testa, U., Castelli, G., & Pelosi, E. (2017) · Medicines · doi:10.3390/medicines4030067 · Cited by 87
“Other studies have supported the identification of an association between some gene signatures and patient’s response to chemo-radiotherapy: thus, Ephrin B3 overexpression correlated with response to therapy in EAC patients [70]; a 5-gene signature (PERP underexpression and DAD1, PRDX6, SELPINB6 and SRF overexpression…”
ResultPotential biomarkers for esophageal cancer
Tan, C., Qian, X., Guan, Z., et al. (2016) · SpringerPlus · doi:10.1186/s40064-016-2119-3 · Cited by 62
“Authors’ contributions All authors were involved in study design or critically revising the manuscript.”
Background
Metadata
- Authors
- Takemasa
- Affiliations
- The University of Osaka (JP)
- Corresponding author
- Takemasa
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2010-09-22
- Volume
- 37
- Issue
- 5
- Pages
- 1113-20
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2146624169
- Semantic Scholar
- 43015f312719ee9489c86a50a769d002fdeeded9
- Cited by
- 31
- References
- 29
- Citations by year
- 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 7 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- esophageal squamous cell carcinoma, chemotherapy response prediction, neoadjuvant chemotherapy, cisplatin-based chemotherapy, gene expression profiling, endoscopic biopsy, chemosensitivity, predictive gene signature, tumor shrinkage
- MeSH terms
- Aged, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Carcinoma, Squamous Cell, Cisplatin, Doxorubicin, Esophageal Neoplasms, Female, Fluorouracil, Humans, Male, Middle Aged, Neoplasm Staging, Prognosis, Cluster Analysis, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, Neoadjuvant Therapy, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples. https://app.cochat.ai/papers/10.3892/ijo_00000763
- The paper
- Takemasa. (2010). Prediction of the response to chemotherapy in advanced esophageal cancer by gene expression profiling of biopsy samples. International Journal of Oncology. https://doi.org/10.3892/ijo_00000763
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.